JP Morgan Chase
ARNA

JP Morgan Chase’s Arena Pharmaceuticals Inc ARNA Stock Holding History

JP Morgan Chase’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-500
Closed -$31K – 5932
2020
Q2 		$31K Buy
+500
New +$27.5K ﹤0.01% 4962
2015
Q1 		– Sell
-3,310
Closed -$115K – 4340
2014
Q4 		$115K Sell
3,310
-50
-1% -$2.03K ﹤0.01% 4091
2014
Q3 		$141K Buy
+3,360
New +$150K ﹤0.01% 4054
2014
Q1 		– Sell
-130
Closed -$8K – 4022
2013
Q4 		$8K Hold
130
– – ﹤0.01% 4040
2013
Q3 		$7K Hold
130
– – ﹤0.01% 4337
2013
Q2 		$10K Buy
+130
New +$10.6K ﹤0.01% 4343

JP Morgan Chase's ARNA Position: Q1 2022 in Review

JP Morgan Chase sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 845,595 shares — an estimated $78.6M sold.

JP Morgan Chase first reported a position in ARNA in Q2 2013 and held it in 24 quarters. The position peaked at $78.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • JP Morgan Chase reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Chase sold 845,595 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $78.6M.
  • JP Morgan Chase first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 24 quarters.
  • JP Morgan Chase's Arena Pharmaceuticals Inc position peaked at $78.6M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.